Our group has shown that HDAC6is regulate PD-L1 in melanoma through STAT3 [19], enhance the immunogenicity of melanoma cells [20], and increase the antitumor efficacy of anti-PD-1 by suppressing M2 macrophages [19, 21, 22]. The gene discussed is STAT3; the disease is melanoma.